Authors


Jeffrey Lipman, MD, DMed(Res)

Latest:

Sepsis Awareness Month: Highlighting the Findings from BLINGIII

Continuous antibiotic infusions show positive results and may improve outcomes for patients with severe sepsis.


Ami Patel, PhD

Latest:

Differentiating Between DNA and mRNA Platforms

Ami Patel, PhD, provides insights on both technologies and how her research center, the Wistar Institute, is involved in DNA vaccine and monoclonal antibody research.


Jaclyn O’Connor, PharmD

Latest:

Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.


Matthew Girgis, PHARMD, BCIDP

Latest:

So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.


James Donovan, MD

Latest:

Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "


Abigail Brooks, MA

Latest:

Antibiotic Stewardship Alone May Be Insufficient for Preventing C Diff Infections

C difficile carriers faced a higher baseline risk for hospital-onset infection compared to noncarriers, and this risk was not significantly influenced by antibiotic use.


Sophie Millard

Latest:

Moving Beyond One-Size-Fits-All: The Future of Microbiome Therapy for C diff and Beyond

In Part 2, Anna Seekatz, PhD and PhD candidate Sophie Millard highlight the need for precision microbial therapies tailored to host-specific gut environments.


Valencia Oglesby, DO

Latest:

Preparing for the Next Long-acting Antiretrovirals

Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.




Jared Baeten, MD, PhD

Latest:

FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

Gilead’s Yeztugo, a long-acting HIV capsid inhibitor, shows 96 to 100% efficacy in phase 3 trials and aims to expand access worldwide through regulatory filings and support programs.


Richard Charles, BPharm

Latest:

What is Driving the Global Expansion of Lyme Disease?

Climate-driven changes and other drivers of the expanding geographic range of Ixodes ticks and Lyme disease are explored.



Paul Feuerstadt, MD

Latest:

Improving Quality of Life For Those With Recurrent C Difficile

Paul Feuerstadt, MD, FACG, AGAF, offers a glimpse of patients dealing with this and insights on improving patients’ quality of life, post-treatment with fecal microbiota, live-jslm (Rebyota [RBL]).


Taryn A. Eubank PharmD, BCIDP

Latest:

Echinocandin Dosing Considerations in Obese Patients: A Review

Obesity significantly impacts the pharmacokinetics (PK) of antifungal drugs like echinocandins, including volume of distribution (Vd) and clearance. However, despite these PK differences, current clinical evidence generally does not support the need for universal dose adjustments in obese patients. Clinicians should consider personalized dosing based on patient characteristics, infection severity, and specific drug properties due to echinocandins' favorable safety profiles.


Anna Zhou, PharmD, BCIDP

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.


Lana Pine

Latest:

Combination Hepatitis C Therapy Efficacious in Those With Previously Untreated Acute Infection

Treatment with glecaprevir/pibrentasvir (G/P) demonstrated a virologic response at post-treatment week 12, which was superior to the prior efficacy threshold.


Christopher M. Bland, PHARMD, FCCP, FIDSA, BCPS

Latest:

Starting an Inpatient Penicillin Skin Testing Service in 2023

Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.


Shruti K. Gohil, MD, MPH

Latest:

INSPIRE Trials: Reducing Antibiotic Prescribing For Skin and Soft Tissue And Abdominal Infections

Led by Shruti K. Gohil, MD, MPH, the trials examined how computerized physician order entry prompts can reduce the use of extended-spectrum antibiotics in hospitalized patients while maintaining patient safety.


Myeongji Kim, MD

Latest:

Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation Infections

There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.


Mohamed Hisham, PharmD, BCCCP, BCIDP

Latest:

All About the JUICE: Justifying Use of Non-Carbapenems for Infected NeCrotizing PancrEatitis

Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.


Alice Hemenway, PharmD, BCPS, BCIDP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.


Lois Levine, MA

Latest:

What You Need to Know About 3 Rare Infectious Eye Diseases

Eric D. Donnenfeld, MD, discusses 3 uncommon yet highly infectious eye diseases, emphasizing the importance of timely treatment and preventative measures.


Jelena Lewis, PharmD, BCACP

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Marian Freedman

Latest:

Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.


Georges C Benjamin, MD, FACP

Latest:

Clinicians Discuss the State of Vaccines Today

A panel discusses how vaccine policy under new federal government policies, why misinformation has flourished and what individual providers can do to win back patient trust.


Matthew J. Grant, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Robert Walker, MD

Latest:

Novavax Seeks Full FDA Approval for COVID-19 Vaccine

Robert Walker, MD discussed the company's application for full licensure and the importance of vaccination.


Tavell Kindall, PhD, DNP, APRN, FNP

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Emily Olsen, PhD

Latest:

Finding a Standard Course of Treatment for Bartonella Infections

Emily Olsen, PhD, offers some insights on this underdiagnosed infection, including describing antimicrobial studies, particularly in biofilm and intracellular environments. Her findings look to create a standardized approach for treating all forms of the different presentations of bartonellosis.

© 2025 MJH Life Sciences

All rights reserved.